CAMLINFINE share price, P/E, ROE & financials

Camlin Fine Sciences (CAMLINFINE) is loss-making over the last 12 months, losing ₹80 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹76.03, 61% below its 52-week high. Sales grew 0.8% a year over 3 years. Debt is 0.74× equity. It is a small-cap company with a market cap of ₹1,461 Cr, ranked 73rd of 204 Specialty Chemicals companies by market cap; the shares fell 61% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹75.95
Day high: ₹76.55
Day low: ₹74.60
Prev. close: ₹76.13
Volume: 4.4 L

Health check

6 to check

ReturnsBehind
−61.2% over a year, better than 0 of 7 peers.
Price tagLoss-making
Earnings were negative over the last 12 months.
GrowthUnder pressure
Sales +0.8%, profit −19.1% a year over 3 years, but loss-making now.
ProfitabilityWeak
ROCE 2.5% vs peer median 24.4%.
Balance sheetStretched
Debt 0.74× equity, interest covered 0.5×, Piotroski 5 of 9.
Red flags4 to check
Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹1,461 Cr, #73 of 204 in its industry by size.

Defensive

Beta 0.67 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹1,877 Cr · profit ₹−80 Cr

Market cap: ₹1,461 Cr; Small cap
P/E: n/a; Industry 22.1
Price to book: 1.50; Peers 13.33
Dividend yield: 0.00%
ROE: −9.6%; Peers 23.0%
ROCE: 2.5%; Peers 24.4%
Debt to equity: 0.74; Debt ₹688 Cr
EPS (TTM): −₹3.00; Face value ₹1
OPM (TTM): 3.7%; Net margin −0.4%
Sales growth: +27.5%; Latest quarter vs a year ago
Profit growth: n/a; Year-ago quarter not reported
Price to sales: 0.78; EV/EBITDA 42.6

Strengths

Quarterly sales up 27.5% on a year ago.
Positive operating cash flow in each of the last 4 years.

Risks to check

Loss-making over the last twelve months.
Return on equity is low at −9.6%.
61% below its 52-week high.
Interest coverage of only 1.8×.

Derived automatically from reported figures. Not a recommendation.

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl…

Headquarters: Mumbai
Employees: 674
Sector: Basic Materials
ISIN: INE052I01032
Website: camlinfs.com

Price range

52 weeks

₹73.25₹195.41

Today

₹74.60₹76.55

Avg volume (3M): 11.4 L
1-year return: minus 61.2%
From 52-week high: minus 61.1%

Peers · Specialty Chemicals

Capital-heavy industry columns

Compare with peers Screen the whole industry

Company
ASIANPAINTAsian Paints	2,546.00	plus 0.88%	2,44,025	50.5	35.0	24.4%	18.9%	0.21	1.1%	plus 1.5%
SOLARINDSSolar Industries India	18,608.00	plus 0.48%	1,68,384	74.4	64.1	29.5%	27.8%	0.22	12.4%	plus 35.9%
PIDILITINDPidilite Industries	1,579.00	plus 1.63%	1,60,827	60.0	44.4	28.5%	23.5%	0.03	7.4%	plus 6.8%
LINDEINDIALinde India	6,859.00	plus 8.73%	58,496	118.4	64.2	16.3%	31.5%	0.23	–	plus 5.4%
BERGEPAINTBerger Paints India	478.35	minus 5.28%	55,776	45.4	29.4	20.6%	15.3%	0.15	4.2%	minus 6.0%
FLUOROCHEMGujarat Fluorochemicals	4,665.50	minus 0.94%	51,251	75.9	44.0	9.6%	24.1%	0.26	−4.5%	plus 28.0%
ACUTAASAcutaas Chemicals	3,786.60	plus 0.42%	31,001	70.9	64.1	27.7%	39.4%	0.01	29.4%	plus 105.6%
CAMLINFINECamlin Fine Sciences	76.03	minus 0.13%	1,461	–	17.1	2.5%	11.4%	0.72	0.8%	minus 61.2%
Median of 7 peers	–	0.48%	58,496	70.9	44.4	24.4%	24.1%	0.21	5.8%	6.8%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
408	460	457	425	520
387	424	449	404	517
20.3	36.3	7.8	21.2	3.2
5.0%	7.9%	1.7%	5.0%	0.6%
6.6	−2.3	17.5	29.5	11.1
13.9	15.2	18.9	27.2	16.3
16.1	18.8	16.7	20.8	19.2
–	–	−17.5	−7.9	−11.1
−3.2	−0.1	−27.9	−5.3	−32.3
0.8%	−6405.3%	−0.2%	118.5%	1.4%
−10	−14.4	−36.2	88.2	−31.7
-0.53	-0.77	-1.91	4.54	-1.65

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +0.8%
Profit CAGR 3Y: −19.1%
EPS CAGR 3Y: −24.4%
ROE: −9.6%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
1,671	1,436	1,598	1,711
–	minus 14.1%	+11.2%	+7.1%
1,487	1,194	1,358	1,590
184	242	240	121
11.0%	16.9%	15.0%	7.1%
13	−15.4	−24.5	8.7
41.1	67.6	74	65.6
62.5	78.6	73.7	74
−13	−22.1	−3.1	−22.3
80.4	58.6	64.6	−32
50.5%	9.6%	−0.8%	1.4%
52.1	−92.8	−139	27.6
3.33	-5.49	-8.03	1.44

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
15.7	16.7	18.8	19.2
804	848	883	1,022
801	683	652	720
440	404	470	563
2,060	1,952	2,024	2,324
839	807	659	664
45	50.4	15	38.7
1.8	1.7	1.7	5.5
95.2	81.2	143	112
1,079	1,011	1,205	1,504
2,060	1,952	2,024	2,324

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
50.9	139	23	82.1
−125	−66.5	−75.3	−53
59.7	−86	76.2	−24.6
−14.1	−13.5	23.8	4.5
−144	−60.6	−42.4	−57.6
−93.4	78.4	−19.5	24.5
−13.9	−28.1	–	–

Shareholding pattern

Source: NSE filings

48.0%

promoters

Promoters48.03%
Public51.97%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	48.03%	51.97%	0.00
30 Jun 2026	48.03%	51.97%	0.00
31 Mar 2026	48.03%	51.97%	0.00
31 Dec 2025	48.03%	51.97%	0.00
30 Nov 2025	48.03%	51.97%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you